ID SAP3_MOUSE Reviewed; 193 AA. AC Q60648; Q61610; Q61819; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 2. DT 24-JAN-2024, entry version 159. DE RecName: Full=Ganglioside GM2 activator {ECO:0000305}; DE AltName: Full=Cerebroside sulfate activator protein; DE AltName: Full=GM2-AP; DE AltName: Full=Sphingolipid activator protein 3; DE Short=SAP-3; DE Flags: Precursor; GN Name=Gm2a {ECO:0000312|MGI:MGI:95762}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE. RC STRAIN=C57BL/6 X CBA; TISSUE=Liver; RX PubMed=7713516; DOI=10.1006/geno.1994.1674; RA Yamanaka S., Johnson O.N., Lyu M.S., Kozak C.A., Proia R.L.; RT "The mouse gene encoding the GM2 activator protein (Gm2a): cDNA sequence, RT expression, and chromosome mapping."; RL Genomics 24:601-604(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=7689829; DOI=10.1042/bj2940227; RA Bellachioma G., Stirling J.L., Orlacchio A., Beccari T.; RT "Cloning and sequence analysis of a cDNA clone coding for the mouse GM2 RT activator protein."; RL Biochem. J. 294:227-230(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=C57BL/6 X CBA; RX PubMed=9060405; DOI=10.1007/s003359900364; RA Bertoni C., Appolloni M.G., Stirling J.L., Li S.C., Li Y.T., Orlacchio A., RA Beccari T.; RT "Structural organization and expression of the gene for the mouse GM2 RT activator protein."; RL Mamm. Genome 8:90-93(1997). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Mammary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, Pancreas, RC Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 32-193 IN COMPLEX WITH RP LYSOPHOSPHATIDYLCHOLINE, FUNCTION, DISULFIDE BONDS, AND MUTAGENESIS OF RP TYR-168. RX PubMed=16216074; DOI=10.1021/bi050668w; RA Wright C.S., Mi L.Z., Lee S., Rastinejad F.; RT "Crystal structure analysis of phosphatidylcholine-GM2-activator product RT complexes: evidence for hydrolase activity."; RL Biochemistry 44:13510-13521(2005). CC -!- FUNCTION: Binds gangliosides and stimulates ganglioside GM2 CC degradation. It stimulates only the breakdown of ganglioside GM2 and CC glycolipid GA2 by beta-hexosaminidase A. It extracts single GM2 CC molecules from membranes and presents them in soluble form to beta- CC hexosaminidase A for cleavage of N-acetyl-D-galactosamine and CC conversion to GM3. The large binding pocket can accommodate several CC single chain phospholipids and fatty acids, GM2A also exhibits some CC calcium-independent phospholipase activity. Has cholesterol transfer CC activity (By similarity). {ECO:0000250|UniProtKB:P17900, CC ECO:0000269|PubMed:16216074}. CC -!- CATALYTIC ACTIVITY: CC Reaction=cholesterol(in) = cholesterol(out); Xref=Rhea:RHEA:39747, CC ChEBI:CHEBI:16113; Evidence={ECO:0000250|UniProtKB:P17900}; CC -!- SUBCELLULAR LOCATION: Lysosome. CC -!- TISSUE SPECIFICITY: Widely expressed. Most abundant in kidney and CC testis. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U09816; AAA21543.1; -; mRNA. DR EMBL; L19526; AAA61929.1; -; mRNA. DR EMBL; U34359; AAB06275.1; ALT_SEQ; Genomic_DNA. DR EMBL; U34356; AAB06275.1; JOINED; Genomic_DNA. DR EMBL; U34357; AAB06275.1; JOINED; Genomic_DNA. DR EMBL; U34358; AAB06275.1; JOINED; Genomic_DNA. DR EMBL; BC004651; AAH04651.1; -; mRNA. DR CCDS; CCDS24707.1; -. DR PIR; S35613; S35613. DR RefSeq; NP_034429.1; NM_010299.3. DR PDB; 2AGC; X-ray; 2.50 A; A=32-193. DR PDBsum; 2AGC; -. DR AlphaFoldDB; Q60648; -. DR SMR; Q60648; -. DR BioGRID; 199959; 1. DR STRING; 10090.ENSMUSP00000000608; -. DR GlyCosmos; Q60648; 1 site, No reported glycans. DR GlyGen; Q60648; 1 site. DR PhosphoSitePlus; Q60648; -. DR SwissPalm; Q60648; -. DR EPD; Q60648; -. DR jPOST; Q60648; -. DR MaxQB; Q60648; -. DR PaxDb; 10090-ENSMUSP00000000608; -. DR ProteomicsDB; 256701; -. DR Pumba; Q60648; -. DR Antibodypedia; 2212; 506 antibodies from 33 providers. DR Ensembl; ENSMUST00000000608.8; ENSMUSP00000000608.8; ENSMUSG00000000594.8. DR GeneID; 14667; -. DR KEGG; mmu:14667; -. DR UCSC; uc007iyw.2; mouse. DR AGR; MGI:95762; -. DR CTD; 2760; -. DR MGI; MGI:95762; Gm2a. DR VEuPathDB; HostDB:ENSMUSG00000000594; -. DR eggNOG; ENOG502S05S; Eukaryota. DR GeneTree; ENSGT00390000003288; -. DR HOGENOM; CLU_108261_0_0_1; -. DR InParanoid; Q60648; -. DR OMA; WIKVPCV; -. DR OrthoDB; 23272at2759; -. DR PhylomeDB; Q60648; -. DR TreeFam; TF353575; -. DR Reactome; R-MMU-6798695; Neutrophil degranulation. DR Reactome; R-MMU-9840310; Glycosphingolipid catabolism. DR BioGRID-ORCS; 14667; 3 hits in 80 CRISPR screens. DR ChiTaRS; Gm2a; mouse. DR EvolutionaryTrace; Q60648; -. DR PRO; PR:Q60648; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; Q60648; Protein. DR Bgee; ENSMUSG00000000594; Expressed in gastrula and 267 other cell types or tissues. DR ExpressionAtlas; Q60648; baseline and differential. DR GO; GO:0009898; C:cytoplasmic side of plasma membrane; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell. DR GO; GO:0005739; C:mitochondrion; HDA:MGI. DR GO; GO:0004563; F:beta-N-acetylhexosaminidase activity; IMP:MGI. DR GO; GO:0008047; F:enzyme activator activity; IDA:MGI. DR GO; GO:0005319; F:lipid transporter activity; IBA:GO_Central. DR GO; GO:0006689; P:ganglioside catabolic process; IMP:MGI. DR GO; GO:0007611; P:learning or memory; IMP:MGI. DR GO; GO:0019915; P:lipid storage; IMP:MGI. DR GO; GO:0006869; P:lipid transport; IBA:GO_Central. DR GO; GO:0051651; P:maintenance of location in cell; IMP:MGI. DR GO; GO:0050877; P:nervous system process; IMP:MGI. DR GO; GO:0050885; P:neuromuscular process controlling balance; IMP:MGI. DR GO; GO:0009313; P:oligosaccharide catabolic process; IMP:MGI. DR Gene3D; 2.70.220.10; Ganglioside GM2 activator; 1. DR InterPro; IPR028996; GM2-AP. DR InterPro; IPR036846; GM2-AP_sf. DR InterPro; IPR003172; ML_dom. DR PANTHER; PTHR17357:SF0; GANGLIOSIDE GM2 ACTIVATOR; 1. DR PANTHER; PTHR17357; GM2 GANGLIOSIDE ACTIVATOR PROTEIN; 1. DR Pfam; PF02221; E1_DerP2_DerF2; 1. DR SMART; SM00737; ML; 1. DR SUPFAM; SSF63707; Ganglioside M2 (gm2) activator; 1. DR Genevisible; Q60648; MM. PE 1: Evidence at protein level; KW 3D-structure; Disulfide bond; Glycoprotein; Hydrolase; Lipid metabolism; KW Lysosome; Reference proteome; Signal; Sphingolipid metabolism. FT SIGNAL 1..20 FT /evidence="ECO:0000255" FT CHAIN 21..193 FT /note="Ganglioside GM2 activator" FT /id="PRO_0000031643" FT CARBOHYD 151 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 39..183 FT /evidence="ECO:0000269|PubMed:16216074" FT DISULFID 99..106 FT /evidence="ECO:0000269|PubMed:16216074" FT DISULFID 112..138 FT /evidence="ECO:0000269|PubMed:16216074" FT DISULFID 125..136 FT /evidence="ECO:0000269|PubMed:16216074" FT MUTAGEN 168 FT /note="Y->S: Abolishes phospholipid binding." FT /evidence="ECO:0000269|PubMed:16216074" FT CONFLICT 53 FT /note="I -> T (in Ref. 1; AAA21543)" FT /evidence="ECO:0000305" FT STRAND 35..39 FT /evidence="ECO:0007829|PDB:2AGC" FT HELIX 40..42 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 44..58 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 60..74 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 81..90 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 93..96 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 107..109 FT /evidence="ECO:0007829|PDB:2AGC" FT HELIX 111..118 FT /evidence="ECO:0007829|PDB:2AGC" FT TURN 127..133 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 142..153 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 165..176 FT /evidence="ECO:0007829|PDB:2AGC" FT STRAND 179..190 FT /evidence="ECO:0007829|PDB:2AGC" SQ SEQUENCE 193 AA; 20824 MW; 59CC4ABE56FA1FC7 CRC64; MHRLPLLLLL GLLLAGSVAP ARLVPKRLSQ LGGFSWDNCD EGKDPAVIKS LTIQPDPIVV PGDVVVSLEG KTSVPLTAPQ KVELTVEKEV AGFWVKIPCV EQLGSCSYEN ICDLIDEYIP PGESCPEPLH TYGLPCHCPF KEGTYSLPTS NFTVPDLELP SWLSTGNYRI QSILSSGGKR LGCIKIAASL KGR //